Implementation of an electronic nose for real -time identification of odour emission peaks at a wastewater treatment plant.

This paper proposes a novel approach for the real-time monitoring of odour emissions from a WasteWater Treatment Plant (WWTP) using an Instrumental Odour Monitoring System (IOMS). The plant is characterized by unpredictable odour peaks at its arrival tank (AT), generating nuisance and complaints in the population living nearby the plant. Odour peaks are most likely due to the conferment of non-identified and malodorous wastewaters coming from various industrial activities. Due to the high variability of sources collecting their wastewaters to the WWTP, a new methodology to train the IOMS, based on the use of a one-class classifier (OCC), has been exploited. The OCC enables to detect deviations from a "Normal Operating Region" (NOR), defined as to include odour concentrations levels unlikely to cause nuisance in the citizenship. Such deviations from the NOR thus should be representative of the odour peaks. The results obtained prove that the IOMS is able to detect real-time alterations of odour emissions from the AT with an accuracy on independent validation data of about 90% (CI95% 55-100%). This ability of detecting anomalous conditions at the AT of the WWTP allowed the targeted withdrawal of liquid and gas samples in correspondence of the odour peaks, then subjected to further analyses that in turn enabled to investigate their origin and take proper counteractions to mitigate the WWTP odour impact.

Accuracy of a new electronic nose for prostate cancer diagnosis in urine samples.

OBJECTIVE: To evaluate the accuracy of a new electronic nose to recognize prostate cancer in urine samples. METHODS: A blind, prospective study on consecutive patients was designed. Overall, 174 subjects were included in the study: 88 (50.6%) in prostate cancer group, and 86 (49.4%) in control group. Electronic nose performance for prostate cancer was assessed using sensitivity and specificity. The diagnostic accuracy of electronic nose was reported as area under the receiver operating characteristic curve. RESULTS: The electronic nose in the study population reached a sensitivity 85.2% (95% confidence interval 76.1-91.9; 13 false negatives out of 88), a specificity 79.1% (95% confidence interval 69.0-87.1; 18 false positives out of 86). The accuracy of the electronic nose represented as area under the receiver operating characteristic curve 0.821 (95% confidence interval 0.764-0.879). CONCLUSIONS: The diagnostic accuracy of electronic nose for recognizing prostate cancer in urine samples is high, promising and susceptible to supplemental improvement. Additionally, further studies will be necessary to design a clinical trial to validate electronic nose application in diagnostic prostate cancer nomograms.

Drift compensation on electronic nose data for non-invasive diagnosis of prostate cancer by urine analysis.

Diagnostic protocol for prostate cancer (KP) is affected by poor accuracy and high false-positive rate. The most promising innovative approach is based on urine analysis by electronic noses (ENs), highlighting a specific correlation between urine alteration and KP presence. Although EN could be exploited to develop non-invasive KP diagnostic tools, no study has already introduced EN into clinical practice, most probably because of drift issues that hinder EN scaling up from research objects to large-scale diagnostic devices. This study, proposing an EN for non-invasive KP detection, describes the data processing protocol applied to a urine headspace dataset acquired over 9 months, comprising 81 patients with KP and 41 controls, for compensating the drift. It proved effective in mitigating drift on 1-year-old sensors by restoring accuracy from 55% up to 80%, achieved by new sensors not subjected to drift. The model achieved, on double-blind validation, a balanced accuracy of 76.2% (CI95% 51.9-92.3).